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Abstract
Background: The pathology of Alzheimer's disease (AD) is comprised of extracellular amyloid
plaques, intracellular tau tangles, dystrophic neurites and neurodegeneration. The mechanisms by
which these various pathological features arise are under intense investigation. Here, expanding
upon pilot gene expression studies, we have further analyzed the relationship between Na+/K+
ATPase and amyloid using APP+PS1 transgenic mice, a model that develops amyloid plaques and
memory deficits in the absence of tangle formation and neuronal or synaptic loss.
Results: We report that in addition to decreased mRNA expression, there was decreased overall
Na+/K+ ATPase enzyme activity in the amyloid-containing hippocampi of the APP+PS1 mice
(although not in the amyloid-free cerebellum). In addition, dual immunolabeling revealed an absence
of Na+/K+ ATPase staining in a zone surrounding congophilic plaques that was occupied by
dystrophic neurites. We also demonstrate that cerebral Na+/K+ ATPase activity can be directly
inhibited by high concentrations of soluble Aβ.
Conclusions: The data suggest that the reductions in Na+/K+ ATPase activity in Alzheimer tissue
may not be purely secondary to neuronal loss, but may results from direct effects of amyloid on
this enzyme. This disruption of ion homeostasis and osmotic balance may interfere with normal
electrotonic properties of dendrites, blocking intraneuronal signal processing, and contribute to
neuritic dystrophia. These results suggest that therapies aimed at enhancing Na+/K+ ATPase
activity in AD may improve symptoms and/or delay disease progression.
Background
Alzheimer's disease (AD) has several well-characterized
post-mortem pathological markers that include both glio-
sis and dystrophic neurites surrounding extracellular amy-
loid plaques. In addition, intracellular tangles of hyper-
phosphorylated tau and massive neurodegeneration are
seen later in the disease process. Mutated forms of both
amyloid precursor protein (APP) and presenilin 1 (PS1)
lead to an increased rate of amyloid deposition and there-
fore an earlier onset of the dementia associated with AD
[1]. Doubly transgenic mice expressing these human
mutants of the APP [2] and PS1 [3] genes (APP+PS1 mice;
[4] exhibit a large amount of amyloid deposition and glio-
sis without the formation of tangles or neuron loss, and
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yet they still develop anterograde amnesia as they age,
similar to what is seen in the early stages of AD [5]. Mem-
ory deficits without the loss of neurons indicate that amy-
loid-associated disruption of some step in neural
processing can result in memory deficits.
Previously we have described decreased expression of
genes critical for learning and memory and impaired
induction of several immediate early genes (IEGs) in aged,
memory deficient APP+PS1 mice [6,7]. Increased neural
activity during learning is argued to be a primary inducing
stimulus for these IEGs [8]. One possible mechanism to
describe this phenomenon would be that amyloid is
diminishing the ability of neurons to facilitate sufficient
electrical signaling to induce changes in synaptic plasticity
essential for memory consolidation. Here we present evi-
dence that in addition to decreased expression of Na+/K+
ATPase mRNA as previously described [6,7], the activity of
this enzyme is significantly decreased in the APP+PS1 hip-
pocampus but not in the amyloid-free cerebellum. Per-
haps not surprisingly ouabain, an Na+/K+ ATPase
inhibitor, has been shown to impair memory consolida-
tion [9,10]. We decided to investigate further the interac-
tions of Aβ and Na+/K+ ATPase activity to understand
better the potential role of this enzyme in AD and mem-
ory dysfunction.
Results
We used the APP+PS1 transgenic mouse model to better
understand how the deposition of amyloid contributes to
the consistent memory loss seen in these animals [11-14].
Specifically, we have found that Na+/K+ ATPase, a protein
critical for not only brain function, but survival, is
adversely affected by the presence of amyloid and this
interaction may be driving a major pathological event in
the progression of amyloid-associated dementia.
In order to determine if our early observation regarding
reduced mRNA for Na+/K+ ATPase was functionally
meaningful, we measured total and ouabain-sensitive
ATPase activity in APP+PS1 brain homogenates compared
to those from non-transgenic littermates using a standard
colorimetric assay. Using ouabain as a selective inhibitor
of Na+/K+ ATPase, we demonstrated that the specific
enzymatic activity was significantly reduced by ~25% in
the hippocampi of aged, memory-deficient APP+PS1 mice
compared with non-transgenic littermates (Figure 1B).
The percent reduction in total ATPase activity was similar
to that of specific Na+/K+ ATPase activity, suggesting that
inhibition of is selective for Na+/K+ ATPase (Figure 1A
&1B). In addition, approximately 40% of all the ATP
hydrolysis found in the homogenate was ouabain sensi-
tive, confirming that this enzyme is likely the largest single
site of ATP hydrolysis in brain. The specific activity values
measured here were consistent with those reported 3 dec-
ades ago by Stefanovic et al. [15], testifying to the robust-
ness of the assay method. Upon analysis of the cerebellum
of these mice, we found that the specific enzyme activity
in APP+PS1 transgenics remained equivalent to that in
non-transgenic littermates (Figure 1B); however the over-
all activity of Na+/K+ ATPase in this region was only one
fifth of that in the hippocampus (Figure 1A &1B). Western
blot analyses of cortical homogenates demonstrated a
trend for reduced protein expression, a finding that would
be expected based upon the mRNA analyses (Figure 1C).
Immunohistochemical staining for the Na+/K+ ATPase
αIII subunit was performed using saggital sections from
non-transgenic and APP+PS1 mice. Specific staining was
observed throughout the forebrain. The specificity of the
Na+/K+ ATPase α subunit antibody used for immuno-
chemistry was determined by pre-incubation of the anti-
body with purified Na+/K+ ATPase protein, which
dramatically reduced apparent immunostaining (Figure
2B) compared with normal staining (Figure 2A; amyloid
plaques stained with Congo red dye appear red). Positive
reaction product appeared to be localized to the periphery
of cellular profiles in CA3 of the hippocampus (Figure 3A)
and the insular cortex (Figure 3B), consistent with the
enzyme's membrane-association. Throughout the brain,
the white matter regions appeared to have less intense
staining, than the neuropil, consistent with the larger
numbers of ions crossing the membrane in post-synaptic
potentials than action potentials (thus requiring more
ionic pumping to maintain ionic equilibrium). Addition-
ally, regions with high densities of neuronal somata also
appeared to have less dense staining, reflecting the greater
density of membrane area in dendritic than somatic
regions of neuropil. Similar observations have been made
using [3H] ouabain to mark Na+/K+ ATPase distribution
in brain [16] Another striking observation from images of
the hippocampus in non-transgenic mice (Figure 3C)
demonstrate a decreased intensity of staining along the
dentate granule cell projection pathways within the hilus
and along the mossy fiber projections to CA3 (Figure 3A).
This can also be observed at higher magnification in figure
3A, where there is reduced staining to the left of the
somatic staining in the inner molecular layer. Although
not commented upon, this too can be observed in micro-
graphs of [3H] ouabain autoradiography [17].
Cortical staining (Figure 3D) revealed a fairly uniform
pattern, with the exclusion of white matter. The difference
in Na+/K+ ATPase staining between non-transgenic and
APP+PS1 forebrain areas is the absence of staining where
amyloid plaques are present in the APP+PS1 mice (Figure
3E &3F). Subsequent Congo red staining of these amyloid
plaques confirmed that the loss of Na+/K+ ATPase stain-
ing was not only present in the center of the plaque, but
also in a penumbral zone immediately surrounding theBMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
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Reduced activity and protein levels of the Na+/K+ ATPase enzyme in APP+PS1 mice Figure 1
Reduced activity and protein levels of the Na+/K+ ATPase enzyme in APP+PS1 mice. Activity of total (A) and ouabain-sensitive (B) 
ATPase was assayed colorimetrically in APP+PS1 mice tissue (n = 8, open bars) and non-transgenic littermate tissue (n = 8, 
solid bars), presented here as µmols of phosphate liberated by ATPase per mg of protein per hour. In the amyloid-containing 
hippocampus, there was a significant decrease in the specific activity of ouabain-sensitive ATPase in APP+PS1 mice compared 
to non-transgenic mice, but there was no decrease in cerebellar Na+/K+ ATPase activity. Cerebellar activity was 20% of that 
seen in non-transgenic hippocampus. Panel C shows the quantitation of the optical density of bands corresponding to the 
molecular weight of Na+/K+ ATPase using standard Western blot technique. This reveals a trend for decreased protein levels. 
*** indicates significant differences between APP+PS1 mice and non-transgenic littermates (p < 0.001) when measured by one-
way ANOVA.BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
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congophilic material, resulting in a "halo" (Figure 2A, 3G,
3H &4A). Higher power magnification clearly demon-
strated the lack of Na+/K+ ATPase staining surrounding
the congophilic plaques (Figure 4A and 4B).
These findings led us to postulate that the osmotic imbal-
ance brought on by an absence or inhibition of Na+/K+
ATPase may contribute to the swelling associated with
dystrophic neurites found in the vicinity of congophilic
plaques in APP+PS1 mice and AD patients. We designed a
dual immunostain utilizing immunohistochemical meth-
ods for Na+/K+ ATPase and immunofluorescence meth-
ods for phosphorylated neurofilament, a dystrophic
neurite marker we evaluated earlier [12]. Using this assay,
we were able to demonstrate that the dystrophic neurites
were almost exclusively present within the zone surround-
ing the congophilic plaque that lacked Na+/K+ ATPase
staining. This is represented in a triple staining overlay of
the fluorescent neurites from figure 4C onto the bright
field image of Na+/K+ ATPase and Congo red staining
from figure 4B (Figure 4D). The arrows in figure 4C
demarcate where dystrophic neurites are present.
Finally, to determine whether amyloid could inactivate
Na+/K+ ATPase activity, we measured the activity of puri-
fied cerebral Na+/K+ ATPase after exposure to various
concentrations of Aβ 1–42 peptide in a DMSO+water sus-
pension or a DMSO+neutralized HCl suspension. Figure
5 demonstrates that increasing concentrations of the
DMSO+water Aβ soluble preparation dose-dependently
reduced Na+/K+ ATPase activity, whereas the fibrillar Aβ
preparation suspended in DMSO+neutralized HCl did
not demonstrate the same effect. There were significant
reductions in Na+/K+ ATPase activity at the lower concen-
trations of 112 and 225 µg/ml compared to vehicle, but
maximal reductions were at the highest concentration of
the DMSO+water Aβ suspension (450 µg/ml).
Discussion
Over the past 6 years, our group has characterized various
aspects of the APP+PS1 transgenic mice including their
pathology, behavior, and gene expression. With age, these
mice progressively develop more amyloid plaques sur-
rounded by dystrophic neurites, activated microglia and
astrocytes [12]. With increasing amyloid burden, aged
animals consistently develop memory deficits in the
radial arm water maze (RAWM; [13,18,19], and, there is
as yet no evidence for neuronal or synaptic loss. [6,20,21].
We have also demonstrated that several genes critical for
synaptic plasticity and memory consolidation are down-
regulated in these mice exclusively in those brain regions
which accumulate amyloid [6] and the induction of a sub-
set of immediate-early genes is impaired when the trans-
genic mice are introduced to a novel environment [7].
Here, we show that Na+/K+ ATPase has decreased enzyme
activity in the amyloid-containing hippocampus of
APP+PS1 transgenic mice. We have also demonstrated by
immunohistology that Na+/K+ ATPase protein expression
is reduced in the immediate vicinity of congophilic
plaques, a zone where dystrophic neurites are most prev-
alent, suggesting that disrupted ionic homeostasis may
contribute to their formation. Additionally, high concen-
trations of Aβ 1–42 directly inhibit the activity of Na+/K+
ATPase. This suggests that in the area surrounding amy-
loid plaques, where the local Aβ concentration is likely
high, Na+/K+ ATPase activity may be locally inhibited.
From previous gene expression studies, we found that the
mRNA for the Na+/K+ ATPase αIII subunit was consist-
ently down-regulated ~30% in the hippocampi of
APP+PS1 mice compared to non-transgenic littermates
and to the amyloid-free cerebella [6]. These reductions
were also demonstrated in human Alzheimer's disease
samples, consistent with data from previous investiga-
tions [6,22]. Using a sensitive colorimetric assay to meas-
ure activity of Na+/K+ ATPase modified from Ellis et al.
[23], we were able to demonstrate that in the APP+PS1
hippocampus, the specific activity of ouabain-sensitive
ATPase was significantly reduced (figure 1B) while Na+/
K+ ATPase activity in the amyloid-free cerebellum
remained unperturbed with respect to genotype. Cerebel-
lar activity was substantially lower than that seen in the
non-transgenic hippocampal tissue, perhaps indicative of
the abundant white matter found in this region, where
Na+/K+ ATPase activity is low. These data demonstrate
Verification of Na+/K+ ATPase αIII antibody specificity by  immunohistochemistry following pre-incubation with purified  protein and Western blotting Figure 2
Verification of Na+/K+ ATPase αIII antibody specificity by immu-
nohistochemistry following pre-incubation with purified protein and 
Western blotting. Horizontal sections were immunostained 
for Na+/K+ ATPase αIII with (Panel B) and without (Panel A) 
pre-incubation with 70 µunits of purified enzyme followed by 
Congo red staining. The pre-incubation significantly 
decreased staining, confirming antibody specificity. Scale bar 
= 50 µm.BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
Page 5 of 11
(page number not for citation purposes)
Hippocampal and cortical immunohistochemistry for Na+/K+ ATPase in APP+PS1 mice and non-transgenic littermates Figure 3
Hippocampal and cortical immunohistochemistry for Na+/K+ ATPase in APP+PS1 mice and non-transgenic littermates. Horizontal hip-
pocampal and cortical sections were immunostained for Na+/K+ ATPase αII. The left panels depict hippocampus, while the 
right panels encompass the cerebral cortex. Panels A & B: high power magnification (Scale bar = 8.33 µm) revealed membrane-
localized staining for Na+/K+ ATPase in the insular cortex (Panel B) and CA3 of the hippocampus (Panel A) of non-transgenic 
mice. Panel C: hippocampal staining of non-transgenic mice showed a ubiquitous distribution of Na+/K+ ATPase throughout 
the neuropil, while less staining was apparent along the pyramidal layer of Ammon's horn, the hilus and the granular layer of the 
dentate gyrus. Panel D: cortical staining was also substantial with slight lightening in layers 1 and 2. White matter in both struc-
tures remained unstained. A similar staining pattern was observed in the APP+PS1 mice with the exception of focal non-stained 
areas in the gray matter, presumably where amyloid plaques are located (Panel E [hippocampus] & F [cortex]). Immunostaining 
followed by Congo red histochemistry confirmed that the Na+/K+ ATPase staining was absent not only immediately where 
amyloid was located, but also in a zone surrounding the plaque (Panels G [hippocampus] & H [cortex]). Scale bar for panels C-
H = 120 µm.BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
Page 6 of 11
(page number not for citation purposes)
Dual Immunostaining of Na+/K+ ATPase αIII and dystrophic neurites Figure 4
Dual Immunostaining of Na+/K+ ATPase αIII and dystrophic neurites. Horizontal sections were immunostained for Na+/K+ 
ATPase using DAB with nickel intensification followed by Congo red staining for Aβ plaques. A discernable circumferential void 
in ATPase staining surrounding the plaque was observed (Panel A, scale bar = 50 µm; Panel B, scale bar = 16.67 µm). Immun-
ofluorescent staining of dystrophic neurites using the anti-phosphorylated neurofilament antibody SMI-312 followed by Congo 
red staining demonstrate a close relationship between amyloid plaques and dystrophic neurites (Panel C; white arrows demar-
cate the neurites). Congo red yellow fluorescence was digitally suppressed to more clearly reveal the green-stained neurites 
(scale bar = 16.67 µm). Panel D is a digital overlay of the fluorescein-labeled dystrophic neurite image onto the bright field per-
oxidase-labeled Na+/K+ ATPase + Congo red image which demonstrates that dystrophic neurites are present predominantly 
in the zone devoid of Na+/K+ ATPase staining surrounding the congophilic plaques (scale bar = 16.67 µm).BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
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that the function of Na+/K+ ATPase is perturbed in a brain
region that contains high overall concentrations of Aβ.
Previous investigations have shown that Na+/K+ ATPase
protein levels are decreased in AD tissue but not in normal
aged tissue [24,25], but it is difficult to dissociate the loss
due to neuronal death from any loss caused directly by Aβ
inhibition. This demonstration that reduced activity along
with a trend for reduced protein levels can be determined
in homogenates from animal models of amyloid deposi-
tion argues that at least some of this loss in AD brain is
associated with direct actions of Aβ. In vitro data suggests
that Na+/K+ ATPase activity can be blocked directly by
various Aβ peptide fragments in cultured neurons [26]
and that even the purified enzyme can be inhibited by
high concentrations of Aβ (Figure 5).
When we immunostained transgenic mouse tissue to vis-
ualize the distribution of Na+/K+ ATPase alpha III subu-
nits we found that in areas where congophilic plaque
staining was apparent, Na+/K+ ATPase staining was
absent, and more specifically, there appeared to be no or
little Na+/K+ ATPase staining in a penumbral zone sur-
rounding the plaques stained with Congo red (Figures
3E–H and 4A–B). While most immunostaining protocols
detect voids at the sites where congophilic plaques are
located, these areas appeared somewhat larger in the Na+/
K+ ATPase immunostained sections. This led us to specu-
late about that a reduction in the activity of this extremely
important enzyme may have severe impacts on the func-
tions of neurons in the vicinity of the deposits.
We knew from previous studies that dystrophic neurites
could be visualized surrounding amyloid plaques in the
APP+PS1 mice. And we have demonstrated previously
that proteins such as synaptophysin and APP are in fact
increased in dystrophic neurites [12]. Therefore, we
decided to stain sections for Na+/K+ ATPase and dys-
trophic neurites, along with amyloid plaques using Congo
red, to determine whether Na+/K+ ATPase was absent
from these neurites and in their immediate vicinity. We
found empirically that staining the ATPase with a peroxi-
dase label and the phosphorylated neurofilament with a
fluorescein label to detect dystrophic neurites was the
most effective way to see both markers on the same sec-
tion along with the Congo red stained plaques. Imaging of
these sections revealed that dystrophic neurites are in the
circumferential area surrounding the congophilic amyloid
plaques where Na+/K+ ATPase staining is absent (Figure
4D).
One possible explanation for this putative relationship
would be that Aβ associated inhibition of Na+/K+ ATPase
activity would result in osmotic imbalance and cause the
neurites to begin swelling. In addition to the loss of
electronic properties and accompanying dysregulation of
neuronal signaling, these changes might even feedback to
influence gene expression. Indeed, Huang et al. demon-
strated that cells exposed to ouabain have reduced Na+/
K+ ATPase αIII subunit mRNA expression [27]. An alter-
native pathway may involve interactions of Aβ with sur-
face proteins, such as integrins [28,29]. and focal
adhesion proteins [30] leading to activation of signal
transduction cascades that mediate tyrosine phosphoryla-
tion [31]. Bozulic et al. reported that the tyrosine kinase,
Lyn, can phosphorylate Na+/K+ ATPase resulting in its
removal from the membrane [32]. These findings suggest
that either direct inhibition of Na+/K+ ATPase by amyloid
or its removal due to amyloid-mediated activation of a
signaling cascade, could contribute to the formation of
dystrophic neurites due to osmotic and/or ionic
imbalances.
Aβ has been shown to bind various cell surface proteins
[26,33,34]. and induce neuro-toxicity in vitro [35-37]. To
determine the effect of Aβ 1–42 on Na+/K+ ATPase activ-
ity, we pre-incubated purified Na+/K+ ATPase with Aβ
Amyloid-beta 1–42 peptide inhibits Na+/K+ ATPase activity Figure 5
Amyloid-beta 1–42 peptide inhibits Na+/K+ ATPase activity. Puri-
fied cerebral Na+/K+ ATPase was pre-incubated with vehicle 
or Aβ 1–42, and enzyme activity percentages of the vehicle 
(20 µmols Pi/mg protein/hour) are presented (mean ± SEM). 
"" indicates the values for the soluble (DMSO+water) Aβ 
suspension. "❍ " indicates the values for the fibrillar 
(DMSO+neutralized HCl) Aβ suspension. At the highest con-
centrations, the soluble preparation dramatically reduces 
Na+/K+ ATPase activity compared to both vehicle and the 
fibrillar Aβ preparation. * (p < 0.05) and *** (p < 0.001) indi-
cates significant differences between Aβ and vehicle alone 
when measured by one-way ANOVA.BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
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then colorimetrically measured enzyme activity. Although
both preparations of Aβ did suppress activity at 112 µg/ml
(~10 µM) and 225 µg/ml (~50 µM), it was the highest
concentration (450 µg/ml or ~100 µM) of the soluble Aβ
suspension that precipitated the largest reduction in activ-
ity compared to vehicle, nearly rendering it completely
inactive (Figure 5). The fibrillar Aβ preparation did not
exact the same precipitous decline in activity, demonstrat-
ing that it is not simply an artifact caused by high concen-
trations of a peptide that reduced activity. Further
investigations will be required to determine which physi-
cochemical form of Aβ is causing the reduced activity. This
suggests that the Aβ can directly bind to the Na+/K+
ATPase and decrease its activity. Mark et al. suggests that
the 25–35 amino acid region of the Aβ peptide induces
oxidative stress thereby impairing Na+/K+ ATPase activity
[26], and the findings presented herein are consistent with
this earlier work.
Conclusions
These data indicate that Aβ deposition in transgenic mice
is associated with reduced activity of Na+/K+ ATPase. In
vitro studies suggest that high concentrations of Aβ can
quickly inactivate the enzyme activity. One area in the
brain that might harbor Aβ concentrations sufficient to
suppress the activity of Na+/K+ ATPase would be the
micro-domain near and immediately around the plaques.
This is the area demonstrated to have reduced immunos-
taining for Na+/K+ ATPase, while exhibiting increased
phosphorylated neurofilament staining consistent with
dystrophic neurites. These results lead to the possibility
that one factor contributing to the formation of dys-
trophic neurites is loss of ionic homeostasis. Such changes
might explain the "swollen" nature of these neuronal
processes in the vicinity of plaques. It might also lead to
sufficient disruption of electro-chemical properties as to
disrupt normal information processing and lead to mem-
ory dysfunction. If these suggestions are correct, drugs tar-
geted at activating Na+/K+ ATPase and maintaining ionic
balance in these neurons may benefit Alzheimer's patients
by delaying the onset of neuritic dystrophia and memory
dysfunction.
Methods
Tissue preparation
Mice were bred in our facility and genotyped using previ-
ously described methods [19] The working memory per-
formance of the APP+PS1 mice used in these studies was
impaired when compared to non-transgenic littermates as
published previously [14]; untreated groups were studied
here). For tissue collection, 17–18 month old mice were
deeply anesthetized with pentobarbital (100 mg/kg) and
perfused transcardially with phosphate buffered saline.
Brains were removed and bisected into right and left hem-
ispheres. The right hemisphere was immediately dissected
into regions that were immediately frozen on dry ice,
while the left hemisphere was post-fixed in 4% para-for-
maldehyde for 24 hours and subsequently processed
through a cryo-protection schedule of 10, 20 and 30%
sucrose. Frozen brains were sectioned horizontally on a
sliding microtome at 25 µm and stored in Dulbecco's
phosphate buffered saline plus azide at 4°C.
Na+/K+ ATPase activity assay and amyloid preparation
An assay to detect specific activity of Na+/K+ ATPase by
measuring the release of phosphate was developed using
a variation of the method described by Ellis et al. [23].
Freshly frozen dissected hippocampi, cortex and cerebella
(20–30 mg tissue weight) from APP+PS1 and non-trans-
genic littermates were homogenized using a rotor-stator
homogenizer in 1 ml of cold suspension buffer contain-
ing 85 mM sodium chloride (NaCl), 20 mM potassium
chloride (KCl), 4 mM magnesium chloride (MgCl), 0.2
mM EGTA and 30 mM histidine pH 7.2. Saponin was
added to the samples to a final concentration of 20 µg/ml.
They were then incubated at 37°C for 15 minutes. Protein
concentration was measured by Bradford assay and con-
centrations were adjusted to 10 mg/ml.
In a 96-well plate, 60 µl of ATP buffer containing 140 mM
NaCl, 20 mM KCl, 3 mM MgCl, 30 mM histidine and 3
mM ATP were added to wells. Two sets of samples were
included, one with ATP buffer only and the other with
100 µM of the Na+/K+ ATPase selective inhibitor ouabain
added to the ATP buffer. Subsequently, 10 µl of protein
homogenates were added to the ATP buffer ± ouabain,
which were then mixed by pipetting and incubated at
37°C for 30 minutes. The reaction was stopped by adding
120 µl of an acid molybdate solution consisting of 0.5 g
ammonium molybdate (Sigma, St. Louis, MO) in 0.5 M
sulfuric acid. After mixing, 10 µl of Fiske Subbarow
Reducer (Sigma, St. Louis, MO) was added and wells were
mixed again. The plate was allowed to incubate covered at
room temperature for 10 minutes and then measured
spectrophotometrically at 660 nm. A standard curve of
phosphoric acid dilutions was used to calculate the spe-
cific activity of the ouabain sensitive ATP hydrolysis and
converted to µmols of inorganic phosphate (Pi) liberated/
mg protein/ hour. All reactions were performed in tripli-
cate, which were then averaged to produce the single value
for the sample. Differences between APP+PS1 and non-
transgenic mice were analyzed for significance using one-
way ANOVA. Aβ used for these studies was generated by
resuspending 1 mg of commercially available recom-
binant Aβ 1–42 peptide (rPeptide, Athens, GA) in 221 µl
of 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP, Sigma, St.
Louis, MO) to generate 45 µg Aβ 1–42 films. These films
were resuspended in 2 µl of anhydrous DMSO, followed
by agitation and subsequent addition of either 48 µl of
cold water followed by overnight incubation at 4°C (forBMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
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soluble Aβ preparation) or 10 mM HCl followed by over-
night incubation at 37°C (for fibrillar Aβ preparation).
The acid was neutralized the following day by the addi-
tion of NaOH. These preparations yielded approximately
900 µg/ml suspensions of Aβ.
For analysis of activity inhibition by both preparations of
Aβ, purified Na+/K+ ATPase (from brain; Sigma, St. Louis,
MO) was pre-incubated for 2 hours in a 37°C orbital
shaker separately with 112.5, 225 and 450 µg/ml of either
a DMSO+water Aβ suspension or a DMSO+neutralized
HCl Aβ suspension. Vehicle alone was also used for each
preparation and sample values are indicated as a percent-
age of the "vehicle only" values. Activity was then meas-
ured using the same activity assay as above and
significance was measured using one-way ANOVA com-
paring activity between vehicle treated and Aβ treated.
Western blot
Brain homogenate from cortical tissue was equilibrated to
10 µg of total protein. This homogenate, along with 1 µg
of purified cerebral Na+/K+ ATPase, was diluted 1:1 with
loading buffer containing 4% SDS and 5% β-mercap-
toethanol, heated to 95°C for 5 minutes and loaded onto
a 7.5% Tris-glycine gel which was electrophoresed at 100
mV for one hour in the presence of SDS. The protein was
subsequently transferred onto an Immobilon membrane
(Millipore, Billerica, MA) for one hour at 100 mV. The
blot was rinsed with borate saline + 0.05% Tween-20
(BST) and blocked overnight at 4°C in 5% non-fat dry
milk (NFDM). The following day, a 1:2000 dilution of
rabbit anti-rat Na+/K+ ATPase αIII antibody (Upstate Bio-
tech, Lake Placid, NY) in 0.5% NFDM+BST was applied to
the blot for 1 hour, followed by washing and a subsequent
1 hour incubation with a 1:5000 dilution of hrp-labeled
anti-rabbit IgG (Sigma, St. Louis, MO) in 0.5%
NFDM+BST. After washing, the blot was developed for
chemiluminescence using a luminol substrate kit (Santa
Cruz Biotech, Santa Cruz, CA). Band density was quanti-
fied using the SoftMax Pro program and one-way ANOVA
was used to determine significance.
Histology
Immunohistochemical and immunofluorescence analy-
ses for Na+/K+ ATPase αIII and phosphorylated neurofil-
ament, respectively, were performed on the same 25 µm
free-floating hippocampal sections. Sections were treated
15 minutes with 10% methanol, 3% hydrogen peroxide
and 80% phosphate buffered saline (PBS) to block endog-
enous peroxidase activity, and then washed 3 times with
PBS. Sections were subsequently treated with sodium
borohydride for 15 minutes to reduce background auto-
fluorescence [38] followed by washing with PBS. Sections
were then permeabilized for 30 minutes with 100 mM
lysine, 0.2% triton x-100, 2% goat serum and 2% horse
serum in PBS, and washed 3 times with PBS. Because one
antibody was murine being used on mouse tissue,
endogenous mouse IgG was first blocked with a 1:300
dilution of goat F (ab') 2 anti-mouse IgG (overnight; Pro-
tos Immunoresearch, Burlingame, CA). Sections were
washed the following day and co-incubated with a 1:5000
dilution of a rabbit anti-rat Na+/K+ ATPase αIII IgG
(Upstate Biotech, Lake Placid, NY) and a 1:10,000 dilu-
tion of a mouse monoclonal IgG1 ascites pool specific for
phosphorylated forms of neurofilament (SMI-312; Stern-
berger Monoclonals, Lutherville, MD) in 2% goat serum
and 2% horse serum in PBS. The following day, sections
were washed, and then co-incubated in both a 1:3000
dilution of anti-rabbit biotinylated secondary antibody
(Vector Laboratories, Burlingame, CA) and a 1:100 dilu-
tion of anti-mouse fluorescein conjugated secondary anti-
body (Vector Labs, Burlingame, CA) for 2 hours. After
washing, the tissue was incubated with Vectastain® Elite®
ABC kit (Vector Labs, Burlingame, CA). The tissue was
then washed and stained with a diaminobenzidine: per-
oxide system plus nickel enhancement (DAB/Ni2+), fol-
lowed by final washes. Compact amyloid plaques were
visualized using Congo red staining after sections were
slide mounted and dried [19]. Briefly, slides were incu-
bated in alkaline alcoholic saturated sodium chloride
(AASSC), followed by 0.2% Congo red in AASSC, then
dehydrated and cover-slipped with xylene-free Vecta-
mount (Vector Labs, Burlingame, CA). Other mounting
media were tested, but only Vectamount was suitable for
combined immunohistochemistry, immunofluorescence
and Congo red staining. The extent of nonspecific binding
was assessed in the absence of primary antibodies for all
assays. Specificity of the Na+/K+ ATPase antibody was
confirmed by reduced staining following a 2 hour pre-
incubation of the antibody with purified cerebral Na+/K+
ATPase at a 1 antibody to 4 enzyme molecule ratio. Both
immunostains were characterized individually before the
co-incubation procedure was implemented.
Authors' contributions
C D contributed to the design the study, developed the
activity assay, generated the Aβ preparations, performed
the histology and western blotting, and drafted the article.
M G was responsible for maintenance of the animals used
in the study, prepared the tissue for subsequent analysis,
and assisted in the design. Both D W and D H participated
in the histology and contributed to the coordination of
the study. M B facilitated the investigations and assisted
with histology. M F performed the genotyping of the mice.
D M conceived of the study, and contributed to its design
and coordination, along with helping to draft the manu-
script. All authors read and approved the final
manuscript.BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
Page 10 of 11
(page number not for citation purposes)
Acknowledgements
This work was supported by AG15490 and AG18478 from NIH.
References
1. Selkoe DJ: Clearing the brain's amyloid cobwebs. Neuron 2001,
32:177-180.
2. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang
F, Cole G: Correlative memory deficits, Abeta elevation, and
amyloid plaques in transgenic mice. Science 1996, 274:99-102.
3. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M,
Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L,
R e f o l o  L ,  Z e n k  B ,  H a r d y  J ,  Y o u n k i n  S :  Increased amyloid-
beta42(43) in brains of mice expressing mutant presenilin 1.
Nature 1996, 383:710-713.
4. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P,
Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo
K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K: Accel-
erated Alzheimer-type phenotype in transgenic mice carry-
ing both mutant amyloid precursor protein and presenilin 1
transgenes. Nat Med 1998, 4:97-100.
5. Morgan D: Learning and memory deficits in APP transgenic
mouse models of amyloid deposition.  Neurochem Res 2003,
28:1029-1034.
6. Dickey CA, Loring JF, Eastman PS, Montgomery JR, Gordon M, Mor-
gan DG: Selectively reduced expression of synaptic plasticity-
related genes in APP+PS1 transgenic mice. J Neurosci 2003,
23:5219-5226.
7. Dickey CA, Gordon MN, Mason JE, Wilson NJ, Diamond DM,
Guzowski JF, Morgan D: Amyloid suppresses induction of genes
critical for memory consolidation in APP + PS1 transgenic
mice. J Neurochem 2004, 88:434-442.
8. Dragunow M: A role for immediate-early transcription factors
in learning and memory. Behav Genet 1996, 26:293-299.
9. Watts ME, Mark RF: Separate actions of ouabain and cyclohex-
imide on memory. Brain Res 1971, 25:420-423.
10. Mark RF, Watts ME: Drug inhibition of memory formation in
chickens. I. Long-term memory. Proc R Soc Lond B Biol Sci 1971,
178:439-454.
11. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J,
Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope
C, Gordon M, Arendash GW: A beta peptide vaccination pre-
vents memory loss in an animal model of Alzheimer's
disease. Nature 2000, 408:982-985.
12. Gordon MN, Holcomb LA, Jantzen PT, DiCarlo G, Wilcock D, Boyett
KW, Connor K, Melachrino J, O'Callaghan JP, Morgan D: Time
course of the development of Alzheimer-like pathology in
the doubly transgenic PS1+APP mouse.  Exp Neurol 2002,
173:183-195.
13. Arendash GW, King DL, Gordon MN, Morgan D, Hatcher JM, Hope
CE, Diamond DM: Progressive, age-related behavioral impair-
ments in transgenic mice carrying both mutant amyloid pre-
cursor protein and presenilin-1 transgenes.  Brain Res 2001,
891:42-53.
14. Austin LA, Arendash GW, Gordon G, Diamond DM, DiCarlo G,
Dickey C, Ugen KE, Morgan D: Short-term A-beta vaccinations
do not improve cognitive performance in cognitively-
impaired APP+PS1 mice. Behav Neurosci 2003.
15. Stefanovic V, Ebel A, Hermetet JC, Mandel P: Na+-K+-ATPase
activity in brain regions of C57 and DBA mice. J Neurochem
1974, 22:1139-1141.
16. Brines ML, Gulanski BI, Gilmore-Hebert M, Greene AL, Benz EJJ, Rob-
bins RJ: Cytoarchitectural relationships between [3H]oua-
bain binding and mRNA for isoforms of the sodium pump
catalytic subunit in rat brain.  Brain Res Mol Brain Res 1991,
10:139-150.
17. Maki AA, Baskin DG, Stahl WL: [3H]-ouabain binding sites in rat
brain: distribution and properties assessed by quantitative
autoradiography. J Histochem Cytochem 1992, 40:771-779.
18. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D:
Behavioral changes in transgenic mice expressing both amy-
loid precursor protein and presenilin-1 mutations: lack of
association with amyloid deposits.  Behav Genet 1999,
29:177-185.
19. Gordon MN, King DL, Diamond DM, Jantzen PT, Boyett KV, Hope
CE, Hatcher JM, DiCarlo G, Gottschall WP, Morgan D, Arendash
GW:  Correlation between cognitive deficits and Abeta
deposits in transgenic APP+PS1 mice.  Neurobiol Aging 2001,
22:377-385.
20. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clay-
ton DF, Hyman BT: Nigral and cortical Lewy bodies and dys-
trophic nigral neurites in Parkinson's disease and cortical
Lewy body disease contain alpha-synuclein
immunoreactivity. J Neuropathol Exp Neurol 1998, 57:334-337.
21. Takeuchi A, Irizarry MC, Duff K, Saido TC, Hsiao Ashe K, Hasegawa
M, Mann DM, Hyman BT, Iwatsubo T: Age-related amyloid beta
deposition in transgenic mice overexpressing both Alzhe-
imer mutant presenilin 1 and amyloid beta precursor pro-
tein Swedish mutant is not associated with global neuronal
loss. Am J Pathol 2000, 157:331-339.
22. Chauhan NB, Lee JM, Siegel GJ: Na,K-ATPase mRNA levels and
plaque load in Alzheimer's disease.  J Mol Neurosci 1997,
9:151-166.
23. Ellis DZ, Nathanson JA, Sweadner KJ: Carbachol inhibits Na(+)-
K(+)-ATPase activity in choroid plexus via stimulation of the
NO/cGMP pathway.  Am J Physiol Cell Physiol 2000,
279:C1685-C1693.
24. Harik SI, Mitchell MJ, Kalaria RN: Ouabain binding in the human
brain. Effects of Alzheimer's disease and aging. Arch Neurol
1989, 46:951-954.
25. Liguri G, Taddei N, Nassi P, Latorraca S, Nediani C, Sorbi S: Changes
in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble
enzymes related to energy metabolism in brains of patients
with Alzheimer's disease. Neurosci Lett 1990, 112:338-342.
26. Mark RJ, Hensley K, Butterfield DA, Mattson MP: Amyloid beta-
peptide impairs ion-motive ATPase activities: evidence for a
role in loss of neuronal Ca2+ homeostasis and cell death. J
Neurosci 1995, 15:6239-6249.
27. Huang L, Kometiani P, Xie Z: Differential regulation of Na/K-
ATPase alpha-subunit isoform gene expressions in cardiac
myocytes by ouabain and other hypertrophic stimuli. J Mol
Cell Cardiol 1997, 29:3157-3167.
28. Sabo S, Lambert MP, Kessey K, Wade W, Krafft G, Klein WL: Inter-
action of beta-amyloid peptides with integrins in a human
nerve cell line. Neurosci Lett 1995, 184:25-28.
29. Goodwin JL, Kehrli MEJ, Uemura E: Integrin Mac-1 and beta-amy-
loid in microglial release of nitric oxide.  Brain Res 1997,
768:279-286.
30. Williamson R, Scales T, Clark BR, Gibb G, Reynolds CH, Kellie S, Bird
IN, Varndell IM, Sheppard PW, Everall I, Anderton BH: Rapid tyro-
sine phosphorylation of neuronal proteins including tau and
focal adhesion kinase in response to amyloid-beta peptide
exposure: involvement of Src family protein kinases.  J
Neurosci 2002, 22:10-20.
31. Grace EA, Busciglio J: Aberrant activation of focal adhesion pro-
teins mediates fibrillar amyloid beta-induced neuronal
dystrophy. J Neurosci 2003, 23:493-502.
32. Bozulic LD, Dean WL, Delamere NA: The influence of Lyn kinase
on Na,K-ATPase in porcine lens epithelium. Am J Physiol Cell
Physiol 2004, 286:C90-C96.
33. Dineley KT, Westerman M, Bui D, Bell K, Ashe KH, Sweatt JD: Beta-
amyloid activates the mitogen-activated protein kinase cas-
cade via hippocampal alpha7 nicotinic acetylcholine recep-
tors: In vitro and in vivo mechanisms related to Alzheimer's
disease. J Neurosci 2001, 21:4125-4133.
34. Verdier Y, Penke B: Binding Sites of Amyloid beta-Peptide in
Cell Plasma Membrane and Implications for Alzheimer's
Disease. Curr Protein Pept Sci 2004, 5:19-31.
35. Caughey B, Lansbury PT: Protofibrils, pores, fibrils, and neuro-
degeneration: separating the responsible protein aggregates
from the innocent bystanders.  Annu Rev Neurosci 2003,
26:267-298.
36. Stine WBJ, Dahlgren KN, Krafft GA, LaDu MJ: In vitro characteri-
zation of conditions for amyloid-beta peptide oligomeriza-
tion and fibrillogenesis. J Biol Chem 2003, 278:11612-11622.
37. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft
GA, Klein WL: Alzheimer's disease-affected brain: presence of
oligomeric A beta ligands (ADDLs) suggests a molecular
basis for reversible memory loss. Proc Natl Acad Sci USA 2003,
100:10417-10422.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Neuroscience 2005, 6:7 http://www.biomedcentral.com/1471-2202/6/7
Page 11 of 11
(page number not for citation purposes)
38. Clancy B, Cauller LJ: Reduction of background autofluores-
cence in brain sections following immersion in sodium
borohydride. J Neurosci Methods 1998, 83:97-102.